Walgreens Boots Alliance Goes Private After Sycamore Partners Acquisition
ByAinvest
Thursday, Aug 28, 2025 12:21 pm ET1min read
WBA--
Under the terms of the deal, Sycamore Partners will acquire WBA from Stefano Pessina and his holding company, Alliance Santé Participations S.A. The acquisition includes a cash consideration of $11.45 per share and a non-transferable right to receive up to $3.00 in cash per share from the future monetization of WBA's debt and equity interests in VillageMD [1]. This transaction represents a premium of up to 63% on WBA's closing share price of $8.85 on December 9, 2024 [1].
The acquisition has led to significant changes within the company. WBA's various segments, including VillageMD, The Boots Group, Shields Health Solutions, CareCentrix, and Walgreens, will now operate as independent businesses. Sycamore has appointed Mike Motz, former CEO of Staples U.S. Retail, as the new CEO of Walgreens. Motz will oversee the company's transition to a private entity and focus on its core pharmacy and retail platform [2].
Stefano Pessina, the long-time chairman of WBA, will remain involved in the company's operations after reinvesting his family's shares. He will continue to support the company alongside Sycamore Partners [2].
The acquisition is part of Sycamore Partners' strategy to invest in and grow private companies. The deal was facilitated by a consortium of financial advisors, including UBS Investment Bank, Goldman Sachs, J.P. Morgan, Citi, and Wells Fargo, as well as legal and regulatory counsel [1][2].
References:
[1] https://www.marketscreener.com/news/sycamore-partners-management-l-p-completed-the-acquisition-of-walgreens-boots-alliance-inc-from-s-ce7c50dcd98ff524
[2] https://chainstoreage.com/walgreens-names-new-ceo-company-goes-private
Walgreens Boots Alliance (WBA) has been acquired by Sycamore Partners and is now a private company. The deal marks the end of WBA's 124-year history as a publicly traded company on the Nasdaq. The pharmacy chain's various segments will now operate as independent businesses, and Staples CEO Mike Motz will take over as CEO. Longtime chairman Stefano Pessina will remain involved after reinvesting his family's shares.
Walgreens Boots Alliance (WBA), a global pharmacy chain, has been acquired by Sycamore Partners, marking the end of its 124-year history as a publicly traded company on the Nasdaq. The acquisition, completed on August 28, 2025, values WBA at approximately $10 billion [2].Under the terms of the deal, Sycamore Partners will acquire WBA from Stefano Pessina and his holding company, Alliance Santé Participations S.A. The acquisition includes a cash consideration of $11.45 per share and a non-transferable right to receive up to $3.00 in cash per share from the future monetization of WBA's debt and equity interests in VillageMD [1]. This transaction represents a premium of up to 63% on WBA's closing share price of $8.85 on December 9, 2024 [1].
The acquisition has led to significant changes within the company. WBA's various segments, including VillageMD, The Boots Group, Shields Health Solutions, CareCentrix, and Walgreens, will now operate as independent businesses. Sycamore has appointed Mike Motz, former CEO of Staples U.S. Retail, as the new CEO of Walgreens. Motz will oversee the company's transition to a private entity and focus on its core pharmacy and retail platform [2].
Stefano Pessina, the long-time chairman of WBA, will remain involved in the company's operations after reinvesting his family's shares. He will continue to support the company alongside Sycamore Partners [2].
The acquisition is part of Sycamore Partners' strategy to invest in and grow private companies. The deal was facilitated by a consortium of financial advisors, including UBS Investment Bank, Goldman Sachs, J.P. Morgan, Citi, and Wells Fargo, as well as legal and regulatory counsel [1][2].
References:
[1] https://www.marketscreener.com/news/sycamore-partners-management-l-p-completed-the-acquisition-of-walgreens-boots-alliance-inc-from-s-ce7c50dcd98ff524
[2] https://chainstoreage.com/walgreens-names-new-ceo-company-goes-private
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet